Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Agrium Inc. (NYSE: AGU)(TSX: AGU) shares declined 0.09 percent to close at $90.49 a share Thursday. The stock traded between $89.80 and $90.93 on volume of 683,353 shares traded. Analysts at Bank of America Merrill Lynch have recently downgraded the company’s rating to "neutral" from "buy". Shares of Agrium have fallen approximately 12.0 percent in the past year.
Find out more about Agrium including full access to the free equity report at:
www.RDInvesting.com/AGU
Cameco Corporation (NYSE: CCJ)(TSX: CCO) shares declined 0.54 percent to close at $20.08 a share Thursday. The stock traded between $19.81 and $20.21 on volume of 887,017 shares traded. Analysts at Scotia Capital have recently initiated coverage on the company with an "outperform" rating. Shares of Cameco have gained approximately 3.0 percent in the past year.
Find out more about Cameco including full access to the free equity report at:
www.RDInvesting.com/CCJ
Insmed Inc. (NASDAQ: INSM) shares gained 6.01 percent to close at $19.58 a share Thursday. The stock traded between $19.14 and $19.87 on volume of 704,093 shares traded. Analysts at JMP Securities have recently upgraded the company’s rating to "outperform" from "market perform". Shares of Insmed have gained approximately 190.0 percent in the past year.
Find out more about Insmed including full access to the free equity report at:
www.RDInvesting.com/INSM
Mondelez International Inc. (NASDAQ: MDLZ) shares increased 1.55 percent to close at $35.36 a share Thursday. The stock traded between $34.55 and $35.40 on volume of 10.61 million shares traded. Analysts at Credit Suisse have recently downgraded the company’s rating to "neutral" from "outperform". Shares of Mondelez International have gained approximately 32.0 percent in the past year.
Find out more about Mondelez International including full access to the free equity report at:
www.RDInvesting.com/MDLZ
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com